ReviewOncology letters2019
Osteopontin as a biomarker for osteosarcoma therapy and prognosis.
Xingwen Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papertrialcites it
ReviewOncology letters2019
Xingwen Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.